Harguindey, S., Arranz, J. L., Polo Orozco, J. D., Rauch, C., Fais, S., Cardone, R. A., & Reshkin, S. J. (2013). Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs – an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research. BioMed Central.

Harguindey, Salvador, Jose Luis Arranz, Julian David Polo Orozco, Cyril Rauch, Stefano Fais, Rosa Angela Cardone, and Stephan J. Reshkin. Cariporide and Other New and Powerful NHE1 Inhibitors As Potentially Selective Anticancer Drugs – an Integral Molecular/biochemical/metabolic/clinical Approach After One Hundred Years of Cancer Research. BioMed Central, 2013.

Harguindey, Salvador, et al. Cariporide and Other New and Powerful NHE1 Inhibitors As Potentially Selective Anticancer Drugs – an Integral Molecular/biochemical/metabolic/clinical Approach After One Hundred Years of Cancer Research. BioMed Central, 2013.